**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In a retrospective cohort study of 91 patients, two patients \[*ages and sexes not stated*\] were described, who developed ventricular arrhythmias manifested as classic Torsades de pointes (TdP), polymorphic ventricular tachycardia or ventricular fibrillation during off-label use of azithromycin and hydroxychloroquine for COVID-19.

The patients, who were diagnosed with COVID-19, received off-label therapy with azithromycin and hydroxychloroquine \[*routes and dosages not stated*\]. The patients developed ventricular arrhythmias manifested as classic TdP with QT prolongation as indicated in a telemetry rhythm strip (ECG) (one patient) and polymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF) (one patient); with severe multisystem disease secondary to COVID-19 in the latter \[*durations of treatment to reactions onset and outcomes not stated*\].
